Business Description
Medlive Technology Co Ltd
ISIN : KYG5961B1041
Compare
Compare
Traded in other countries / regions
02192.Hong Kong IPO Date
2021-07-15Description
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 537.17 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 215.31 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 19.9 | |||||
| Beneish M-Score | -1.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 34.4 | |||||
| 3-Year EBITDA Growth Rate | 47.7 | |||||
| 3-Year EPS without NRI Growth Rate | 51.4 | |||||
| 3-Year FCF Growth Rate | 36.2 | |||||
| 3-Year Book Growth Rate | 300.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -8.49 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.27 | |||||
| 9-Day RSI | 61.79 | |||||
| 14-Day RSI | 59.66 | |||||
| 6-1 Month Momentum % | -2.54 | |||||
| 12-1 Month Momentum % | -15.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 24.1 | |||||
| Quick Ratio | 24.09 | |||||
| Cash Ratio | 23.19 | |||||
| Days Inventory | 0.39 | |||||
| Days Sales Outstanding | 88.15 | |||||
| Days Payable | 16.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.35 | |||||
| Dividend Payout Ratio | 0.54 | |||||
| Forward Dividend Yield % | 4.03 | |||||
| 5-Year Yield-on-Cost % | 2.31 | |||||
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | 2.45 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61 | |||||
| Operating Margin % | 18.87 | |||||
| Net Margin % | 58.81 | |||||
| FCF Margin % | 16.9 | |||||
| ROE % | 5.31 | |||||
| ROA % | 5.02 | |||||
| ROIC % | 25.5 | |||||
| ROC (Joel Greenblatt) % | 2024.52 | |||||
| ROCE % | 5.46 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.64 | |||||
| Forward PE Ratio | 24.27 | |||||
| PE Ratio without NRI | 22.64 | |||||
| Price-to-Owner-Earnings | 47.38 | |||||
| PS Ratio | 13.3 | |||||
| PB Ratio | 1.18 | |||||
| Price-to-Tangible-Book | 1.25 | |||||
| Price-to-Free-Cash-Flow | 78.37 | |||||
| Price-to-Operating-Cash-Flow | 68.49 | |||||
| EV-to-EBIT | 4.55 | |||||
| EV-to-Forward-EBIT | 11.46 | |||||
| EV-to-EBITDA | 4.48 | |||||
| EV-to-Forward-EBITDA | 9.69 | |||||
| EV-to-Revenue | 2.8 | |||||
| EV-to-Forward-Revenue | 2.25 | |||||
| EV-to-FCF | 16.58 | |||||
| Price-to-Graham-Number | 1.12 | |||||
| Price-to-Net-Current-Asset-Value | 1.27 | |||||
| Price-to-Net-Cash | 1.32 | |||||
| Earnings Yield (Greenblatt) % | 21.98 | |||||
| FCF Yield % | 1.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medlive Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 450.641 | ||
| EPS (TTM) (HK$) | 0.36 | ||
| Beta | 0 | ||
| Volatility % | 58.2 | ||
| 14-Day RSI | 59.66 | ||
| 14-Day ATR (HK$) | 0.338671 | ||
| 20-Day SMA (HK$) | 7.8035 | ||
| 12-1 Month Momentum % | -15.61 | ||
| 52-Week Range (HK$) | 5.59 - 9.9 | ||
| Shares Outstanding (Mil) | 726.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medlive Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medlive Technology Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medlive Technology Co Ltd Frequently Asked Questions
What is Medlive Technology Co Ltd(HKSE:02192)'s stock price today?
The current price of HKSE:02192 is HK$8.15. The 52 week high of HKSE:02192 is HK$9.90 and 52 week low is HK$5.59.
When is next earnings date of Medlive Technology Co Ltd(HKSE:02192)?
The next earnings date of Medlive Technology Co Ltd(HKSE:02192) is 2024-09-20 Est..
Does Medlive Technology Co Ltd(HKSE:02192) pay dividends? If so, how much?
The Dividend Yield %  of Medlive Technology Co Ltd(HKSE:02192) is 2.35% (As of Today), Highest Dividend Payout Ratio of Medlive Technology Co Ltd(HKSE:02192) was 0.54. The lowest was 0.11. And the median was 0.11. The  Forward Dividend Yield % of Medlive Technology Co Ltd(HKSE:02192) is 4.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers